switching between glp 1 agonists chart Glucagon-like peptide-1 receptor and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Many adults stop GLP-1 therapy
Description
GLP-1s often work better for both goals
One consideration unique to covering GLP-1s for anti-obesity is that while plan sponsors will incur new short-term pharmacy costs, expected cost offsets such as lower medical benefit costs may not materialize until years later
PM: Curcumin 500mg + Probiotics Loading Phase: Week 1 at half-dose to assess tolerance, then increase gradually
Their mechanism of action is fascinating: by mimicking a hormone released in the gut, they slow gastric emptying, suppress appetite, and improve insulin responsecreating the impression of a metabolic reset
Research evaluating the utility of insulin therapy for AD and PD is underway
Semaglutide causes gastrointestinal effects (nausea, constipation, diarrhea)
